CIK 0001434647 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in DE · fiscal year ends 12/31
| FY2025 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|
| Revenue (USD) | ||||
| Net income (USD) | -26.8 M | -8.6 M | -12.8 M | |
| Diluted EPS (USD/shares) | 1.35 | -2.11 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-10-13 | 4 | FORM 4 | 2026-10-10 |
| 2026-10-13 | 144 | 144 | |
| 2026-08-17 | 4 | FORM 4 | 2026-08-14 |
| 2026-08-14 | 144 | 144 | |
| 2026-08-14 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-08-12 | 4 | FORM 4 | 2026-08-10 |
| 2026-08-06 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-08-05 | 10-Q | 10-Q | 2026-06-30 |
| 2026-08-05 | 8-K | 8-K items 2.02,9.01 | 2026-08-05 |
| 2026-07-31 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-07-08 | 144 | 144 | |
| 2026-06-23 | 4 | FORM 4 | 2026-06-21 |
| 2026-06-18 | 4 | FORM 4 | 2026-06-04 |
| 2026-06-18 | 4 | FORM 4 | 2026-06-04 |
| 2026-06-18 | 4 | FORM 4 | 2026-06-04 |
| 2026-06-18 | 4 | FORM 4 | 2026-06-04 |
| 2026-06-18 | 4 | FORM 4 | 2026-06-04 |
| 2026-06-18 | 4 | FORM 4 | 2026-06-04 |
| 2026-06-05 | 8-K | 8-K items 5.07,9.01 | 2026-06-04 |
| 2026-05-29 | 4 | FORM 4 | 2026-05-28 |
| 2026-05-13 | 4 | FORM 4 | 2026-05-11 |
| 2026-05-11 | 144 | 144 | |
| 2026-05-06 | 10-Q | 10-Q | 2026-03-31 |
| 2026-05-06 | 8-K | 8-K items 2.02,9.01 | 2026-05-06 |
| 2026-05-06 | SCHEDULE 13G | SCHEDULE 13G |
Forms on file (last 1,000): 4 284, 8-K 203, 10-Q 35, DEFA14A 34, 3 30, SC 13G/A 29, 424B3 24, CORRESP 20. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=ZVRA (0.002 USD), /gw/filings/filings?ticker=ZVRA&form=8-K, /gw/filings/facts?ticker=ZVRA&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange